Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.

about

Prognostic factors of primary gastrointestinal stromal tumors: a cohort study based on high-volume centers.

P2860

Q52653166-1F6692AD-1AE4-46FA-B799-496C09A6E0D7

P2860

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.

Item

http://www.wikidata.org/entity/Q41691560

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chinese consensus guidelines f ...... astrointestinal stromal tumor.

@en

type

Item

label

Chinese consensus guidelines f ...... astrointestinal stromal tumor.

@en

prefLabel

Chinese consensus guidelines f ...... astrointestinal stromal tumor.

@en

P1476

Chinese consensus guidelines f ...... astrointestinal stromal tumor.

@en

P2093

Bo Zhang

http://www.w3.org/2001/XMLSchema#string

Chinese Society Of Clinical On ...... Gastrointestinal Stromal Tumor

http://www.w3.org/2001/XMLSchema#string

Hui Cao

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Ming Wang

http://www.w3.org/2001/XMLSchema#string

Shukui Qin

http://www.w3.org/2001/XMLSchema#string

Tianlong Lin

http://www.w3.org/2001/XMLSchema#string

Xiaobo Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Can laparoscopic surgery be applied in gastric gastrointestinal stromal tumors located in unfavorable sites?: A study based on the NCCN guidelines

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

P304

281-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21147/J.ISSN.1000-9604.2017.04.01

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28947860

http://www.w3.org/2001/XMLSchema#string

P932

5592117

http://www.w3.org/2001/XMLSchema#string

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.

about

P2860

P2860

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932